Decreased bone mineral density in men with metabolic syndrome alone and with type 2 diabetes

Medical Science Monitor

Volumn 15, Issue 1, 2009, Pages

  Yaturu, Subhashini ^a   Humphrey, Stacey ^a   Landry, Christopher ^b   Jain, Sushil K ^c  

^a OVERTON BROOKS VA MEDICAL CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

Bone mineral density; Diabetes; Metabolic syndrome; Osteopenia; Osteoporosis

Indexed keywords

ADULT; AGED; ARTICLE; BONE DENSITY; CONTROLLED STUDY; DISEASE ASSOCIATION; HIP; HIP FRACTURE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOPENIA; OSTEOPOROSIS; SPINE;

BONE DENSITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; HUMANS; MALE; METABOLIC SYNDROME X; OSTEOPOROSIS; PELVIC BONES; SPINE;

EID: 58649094407     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Cummings SR, Melton LJ: Epidemiology and outcomes of osteoporotic fractures. Lancet, 2002; 359(9319): 1761-67
2. Seeman E et al: Reduced bone mass in daughters of women with osteoporosis. N Engl J Med, 1989; 320(9): 554-58
3. Yaturu S, Bryant B, Jain SK: Thiazolidinedione treatment decreases bone mineral density in type 2 diabetic men. Diabetes Care, 2007; 30(6): 1574-76
4. Ohldin A, Floyd J: Unrecognized risks among Veterans with hip fractures: opportunities for improvements. J South Orthop Assoc, 2003; 12(1): 18-22
5. Bonds DE et al: Risk of fracture in women with type 2 diabetes: the Women's Health Initiative Observational Study. J Clin Endocrinol Metab, 2006; 91(9): 3404-10
6. Janghorbani M et al: Prospective study of type 1 and type 2 diabetes and risk of stroke subtypes: the Nurses' Health Study. Diabetes Care, 2007; 30(7): 1730-35
7. Janghorbani M et al: Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol, 2007; 166(5): 495-505
8. Lipscombe LL et al: The risk of hip fractures in older individuals with diabetes: a population-based study. Diabetes Care, 2007; 30(4): 835-41
9. Schwartz AV et al: Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab, 2001; 86(1): 32-38
10. Ahmed LA et al: Diabetes mellitus and the risk of non-vertebral fractures: the Tromso study. Osteoporos Int, 2006; 17(4): 495-500
11. Johnell O et al: Predictive value of BMD for hip and other fractures. J Bone Miner Res, 2005; 20(7): 1185-94
12. Nguyen T et al: Prediction of osteoporotic fractures by postural instability and bone density. BMJ, 1993; 307(6912): 1111-15
13. Nguyen TV et al: Risk factors for osteoporotic fractures in elderly men. Am J Epidemiol, 1996; 144(3): 255-63
14. Isaia G et al: Osteoporosis in type II diabetes. Acta Diabetol Lat, 1987l 24(4): 305-10
15. Wakasugi M et al: Bone mineral density measured by dual energy x-ray absorptiometry in patients with non-insulin-dependent diabetes mellitus. Bone, 1993; 14(1): 29-33
16. Barrett-Connor E, Holbrook TL: Sex differences in osteoporosis in older adults with non-insulin-dependent diabetes mellitus. Jama, 1992; 268(23): 3333-37
17. Weinstock RS et al: Bone mineral density in women with type II diabetes mellitus. J Bone Miner Res, 1989; 4(1): 97-101
18. Nordstrom P, Neovius M, Nordstrom A: Early and rapid bone mineral density loss of the proximal femur in men. J Clin Endocrinol Metab, 2007; 92(5): 1902-8
19. Nordstrom A et al: Bone loss and fracture risk after reduced physical activity. J Bone Miner Res, 2005; 20(2): 202-7
20. Nordstrom A, Olsson T, Nordstrom P: Sustained benefits from previous physical activity on bone mineral density in males. J Clin Endocrinol Metab, 2006; 91(7): 2600-4
21. Grundy SM: Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab, 2007; 92(2): 399-404
22. Grundy SM et al: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 2005; 112(17): 2735-52
23. Hofbauer LC, Schoppet M: Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. Jama, 2004; 292(4): 490-95
24. Jones DH, Kong YY, Penninger JM: Role of RANKL and RANK in bone loss and arthritis. Ann Rheum Dis, 2002; 61(Suppl.2): ii32-39
25. Schett G et al: High-sensitivity C-reactive protein and risk of nontraumatic fractures in the Bruneck study. Arch Intern Med, 2006; 166(22): 2495-501
26. Smith BJ et al: Systemic bone loss and induction of coronary vessel disease in a rat model of chronic inflammation. Bone, 2006; 38(3): 378-86
27. Yamaguchi T et al: Plasma lipids and osteoporosis in postmenopausal women. Endocr J, 2002; 49(2): 211-17
28. von Muhlen D et al: Associations between the metabolic syndrome and bone health in older men and women: the Rancho Bernardo Study. Osteoporos Int, 2007; 18(10): 1337-44
29. Kinjo M, Setoguchi S, Solomon DH: Bone mineral density in adults with the metabolic syndrome: analysis in a population-based U.S. sample. J Clin Endocrinol Metab, 2007; 92(11): 4161-64
30. Grundy SM: United States Cholesterol Guidelines 2001: expanded scope of intensive low-density lipoprotein-lowering therapy. Am J Cardiol, 2001; 88(7B): 23J-27J
31. Schwartz AV et al: Older women with diabetes have a higher risk of falls: a prospective study. Diabetes Care, 2002; 25(10): 1749-54
32. Wallace C et al: Incidence of falls, risk factors for falls, and fall-related fractures in individuals with diabetes and a prior foot ulcer. Diabetes Care, 2002; 25(11): 1983-86
33. Ivers RQ et al: Diabetes and risk of fracture: The Blue Mountains Eye Study. Diabetes Care, 2001; 24(7): 1198-203
34. Gregg EW et al: Diabetes and physical disability among older U.S. adults. Diabetes Care, 2000; 23(9): 1272-77
35. Gregg EW et al: Diabetes and incidence of functional disability in older women. Diabetes Care, 2002; 25(1): 61-67
36. Nicodemus KK, Folsom AR: Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care, 2001; 24(7): 1192-97
37. Kahn SE et al: Rosiglitazone Associated Fractures in Type 2 Diabetes: An Analysis From ADOPT. Diabetes Care, 2008
38. Meymeh RH, Wooltorton E: Diabetes drug pioglitazone (Actos): risk of fracture. CMAJ, 2007; 177(7): 723-24
39. NIH Consensus Development Panel on Osteoporosis Prevention, D.a.T, Osteoporosis prevention, diagnosis, and therapy. Jama, 2001; 285(6): 785-95
40. Broussard DL, Magnus JH: Influence of cardiovascular disease risk factors on the relationship between low bone mineral density and type 2 diabetes mellitus in a multiethnic US population of women and men: a cross-sectional study. Gend Med, 2008; 5(3): 229-38
41. Zhang YH et al: Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways. J Biol Chem, 2001; 276(1): 563-68
42. Gustafson B et al: Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol, 2007; 27(11): 2276-83
43. Kraja AT et al: Do inflammation and procoagulation biomarkers contribute to the metabolic syndrome cluster? Nutr Metab (Lond), 2007; 4(1): 28